ScreenerHero

SE Sweet Earth Holdings Corporation

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · sweetearthskincare.com
0.5100CAD0.00%Mkt Cap: 4.80M $P/E: 2.55

Sweet Earth Holdings Corporation does not have significant operations. Previously, it was involved in cultivating, processing, and selling hemp cannabidiol (CBD) products. The company is based in Vancouver, Canada.

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap4.80M USD
Enterprise Value4.90M USD
Revenue (TTM)—
Gross Profit4.06K USD
Net Income (TTM)133.21K USD
Revenue/Share—
Last Price0.5100 CAD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA87039X1179
Valuation
P/E (Trailing)2.55
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-36.43
EPS (TTM)0.20
EPS (Forward)—
52W Range
—
52W High0.5100 CAD
52W Low0.5100 CAD
Profitability
Gross Margin57.66%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin1891.45%
ROE-63.69%
ROA1033.28%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-120.54K USD
CapEx (TTM)—
FCF Margin—
FCF Yield-28.92%
Net Debt98.71K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.17
Current Ratio0.02
Quick Ratio0.02
Book Value/Sh-0.01 CAD
Cash/Share0.00 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateDec 11, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.12.92M
Float12.91M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio4.0d
Short % Out.0.00%
Shares Short399
Short (prev mo.)399
Technical
SMA 500.5100 (-0.0%)
SMA 2000.5100 (-0.0%)
Beta1.17
S&P 52W Chg16.45%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)100.0
MACD0.0000
MACD Signal0.0000
MACD Hist.+0.0000
BB Upper0.5100 CAD
BB Middle0.5100 CAD
BB Lower0.5100 CAD
BB Width0.00%
ATR (14)0.0000 CAD
Vol Ratio (20d)—